Pilot 5 will use psychophysiological recording techniques as well as classical conditioning theory and methodology to assess learning and memory in patients with Alzheimer's disease (AD). Because AD is accompanied by progressive deterioration in verbal and motor performance, standard neuropsychological methods alone may not be adequate to assess completely the residual cognitive abilities of patients with advanced disease. We will measure facial recognition memory, which is thought to be impaired in patients with AD, by recording their autonomic reactivity to slides of known (famous) faces. Such implicit memory has been detected in previous studies in which verbal recognition was not evident. Skin conductance and heart rate responses of individuals with aD with varying levels of impairment will be measured during randomized computer- controlled slide presentations of known persons, unknown persons, and blanks. Verbal recognition and self-controlled slide viewing durations (timed in millisecond accuracy) will also be obtained and correlated with measures of autonomic reactivity. Controls will be nondemented subjects matched for age and sex. In these same individuals, we will measure autonomic an motor associative learning through the use of classical conditioning. The development of heart rate and eyeblink conditioned responses will be recorded during trials in which an auditory conditioned stimulus (tone) one_second duration is followed and overlapped during the final 500 milliseconds by a light-flash, unconditioned stimulus. The outcomes of these two studies are likely to provide standardized assessment techniques that may be used to assess changes in performance during progression of disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-10
Application #
3790130
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kim, Sangjune; Yun, Seung Pil; Lee, Saebom et al. (2018) GBA1 deficiency negatively affects physiological ?-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798-803
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998

Showing the most recent 10 out of 830 publications